The Latest Breaking News from CME Group

Gold's all-time high $3,509.9! Central banks bought big, but the COT report waves a red flag. Seasonal gains await—Market players, read or regret!

Think interest rates don't matter to your portfolio? Think again! Fed cuts and seasonal trends could unlock profits in Treasuries. Challenge yourself to explore TLT ETF and futures.

CME Group has notably outpaced the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

CME Group (CME) on Wednesday rallied to a new record high, taking out the previous high from early April. CME Group fell on April 23 after its slightly negative Q1 earnings report but has since been on a tear to the upside. CME Group’s revenues are tightly linked to market...

Morgan Stanley upgrades CBOE, CME Group, and MarketAxess (MKTX), forecasting growth as investors hedge volatility and recession risks.

Financial sector giant CME Group is set to announce its Q1 results later this month and analysts expect a notable single-digit growth in earnings.

Gold traders closely monitor market conditions as economic uncertainty drives demand for the precious metal. Concerns over tariffs, inflation, and slowing economic growth have strengthened gold's appeal as a safe-haven asset. Additionally, with the Federal Reserve keeping interest rates steady at its recent meeting, the market is looking for four…

Despite the bullish sentiment in the gold market, traders should remain cautious. Gold has been on a relentless upward trajectory since September 2022, leading some analysts to question whether the metal is already over-priced at these levels. As early investors look to cash in on profits, the risk of a…

Although CME Group has outperformed relative to the financial sector over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Gold soared toward the $3,000 mark on Thursday, reaching an intraday high of $2,973 and briefly surpassing $2,954 in the cash market.

CME Group has significantly outpaced the broader market recently, yet analysts remain cautious about the stock’s prospects.